Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Trading Statement

15 Jan 2016 07:00

RNS Number : 9511L
Exova Group PLC
15 January 2016
Β 

15 January 2016

Exova Group plc

Post-close Trading Update

Exova Group plc ("Exova"), a leading international provider of technically demanding testing, certification and advisory services, today issues the following update on trading.

The Board is pleased to report that trading for November and December 2015 was in line with its expectations and, therefore, full year earnings guidance for the year ended 31 December 2015 is consistent with our Trading Update on 11 November 2015.

Β 

The Group continued to make good progress with its acquisition strategy with the completion of two small bolt-on acquisitions in the United Kingdom. In December 2015, Exova acquired Western Technical Services, a specialist provider of non-destructive testing and inspection of components and equipment in the food, dairy, brewing and pharmaceutical industries, and also completed the acquisition of the environmental monitoring division of Resource and Environmental Consultants Ltd. In a full year these acquisitions are expected to deliver around Β£2m of revenue.

Β 

The Group's full year results to 31 December 2015 will be announced on 3 March 2016.

Β 

Β 

Β 

Contacts

Β 

Ian Middleton / Sophie Moate

Powerscourt Group

Tel. Direct +44 (0)20 7250 1446 / +44 (0)7885 508 527

exova@powerscourt-group.com

Β 

Ian Power, Investor Relations

Exova Group plc

Telephone: +44 (0) 131 476 7619

investor.relations@exova.com

Β 

Β 

About Exova

Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 144Β laboratories and offices in 32 countries and employs around 4,500 people throughout Europe, the Americas, the Middle East and Asia/Asia Pacific.

Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors from health sciences to aerospace, transportation, oil and gas, fire and construction.

This Trading Update release contains forward-looking statements that involve substantial risks and uncertainties and actual results and developments may differ materially from those expressed or implied by these statements by a variety of factors. These forward-looking statements speak only as at the date of this press release. In addition, all projections, valuations and statistical analyses provided in this document may be based on unaudited pro-forma financial information, subjective assessments and assumptions. They may use alternative methodologies that produce different results and should not be relied upon as an accurate prediction of future performance.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTAKQDPOBKDDDD
Date   Source Headline
15th Feb 20169:00 amRNSExova acquires majority stake in Admaterials
10th Feb 20164:35 pmRNSPrice Monitoring Extension
15th Jan 20167:00 amRNSTrading Statement
31st Dec 201512:35 pmRNSPrice Monitoring Extension
31st Dec 20159:00 amRNSNotification of Transactions of Directors & PDMRs
18th Dec 201512:16 pmRNSAppointment of Senior Independent Director
9th Dec 20153:18 pmRNSChange of financial results date
8th Dec 201510:35 amRNSDirector/PDMR Shareholding
30th Nov 20157:00 amRNSAppointment of Chief Financial Officer
11th Nov 20157:00 amRNSTrading Statement
4th Nov 201510:30 amRNSExova appoints Paul Barry as MD for Europe
3rd Nov 201511:14 amRNSNotification of transactions of Directors & PDMRs
21st Oct 20159:18 amRNSDirector/PDMR Shareholding
19th Oct 201511:51 amRNSDirector/PDMR Shareholding
13th Oct 20152:00 pmRNSExova opens Pittsburgh laboratory
5th Oct 201510:00 amRNSExova wins Qatar testing contract
2nd Oct 20159:04 amRNSNotification of transactions of Directors & PDMRs
1st Oct 201510:00 amRNSExova appoints managing director for MEAAP region
28th Sep 20157:00 amRNSAppointment of Chief Financial Officer
10th Sep 201510:23 amRNSDirector/PDMR Shareholding
8th Sep 201510:50 amRNSDirector Declaration
7th Sep 20159:30 amRNSDirector/PDMR Shareholding
1st Sep 201510:57 amRNSExova wins UAE outsourcing deal
28th Aug 20157:01 amRNSDirectorate Change
28th Aug 20157:00 amRNSHalf Yearly Report
6th Aug 20159:11 amRNSTR-1: Notification of Major Interest in Shares
29th Jul 201511:00 amRNSExova wins long term agreement
22nd Jul 201510:00 amRNSExova opens new Malaysia lab
7th Jul 201510:00 amRNSExova extends relationship with Maersk Oil
2nd Jul 20154:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20154:35 pmRNSPrice Monitoring Extension
24th Jun 20151:40 pmRNSDirector/PDMR Shareholding
23rd Jun 20151:33 pmRNSDirector/PDMR Shareholding
17th Jun 20152:50 pmRNSDirector/PDMR Shareholding
9th Jun 201511:00 amRNSExova lands Kaombo Project contract
8th Jun 20152:10 pmRNSDirector/PDMR Shareholding
19th May 201512:20 pmRNSDirector/PDMR Shareholding
14th May 20154:52 pmRNSResult of AGM
14th May 20157:00 amRNSTrading Statement
20th Apr 201512:50 pmRNSExova wins contract with AGDC
20th Apr 20157:00 amRNSChange of Adviser
10th Apr 20159:46 amRNSAnnual Financial Report
16th Mar 20153:05 pmRNSDirector/PDMR Shareholding
4th Mar 20157:00 amRNSFinal Results
24th Feb 201512:55 pmRNSTR-1: Notification of Major Interest in Shares
23rd Feb 20159:00 amRNSExova wins long term agreement with Böhler
9th Feb 201510:00 amRNSExova acquires Environmental Evaluation
4th Feb 201510:30 amRNSExova agrees calibration outsourcing deal
2nd Feb 20157:00 amRNSExova contract wins for testing on Doha Metro
22nd Jan 20159:20 amRNSNotification of New Directorship

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.